Zydus Lifesciences
Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.
Launch date
Employees
Market cap
$15.3b
Enterprise valuation
$15.2b (Public information from Sep 2024)
Share price
INR1058.5 ZYDUSLIFE.NS
Ahmedabad Gujarat (HQ)
Corporate Venture Fund: Zynext Ventures
Financials
Estimates*
| INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 148.2b | 148.3b | 168.8b | 190.2b | 224.4b | 240.7b | 248.4b |
| % growth | 7 % | - | 14 % | 13 % | 18 % | 7 % | 3 % |
| EBITDA | 34.0b | 34.3b | 40.5b | 55.1b | 65.3b | 67.5b | 62.9b |
| % EBITDA margin | 23 % | 23 % | 24 % | 29 % | 29 % | 28 % | 25 % |
| Profit | 21.3b | 44.9b | 19.6b | 38.6b | 45.4b | 47.8b | 44.0b |
| % profit margin | 14 % | 30 % | 12 % | 20 % | 20 % | 20 % | 18 % |
| EV / revenue | 3.2x | 2.6x | 3.0x | 5.3x | 4.9x | 4.4x | 4.2x |
| EV / EBITDA | 14.0x | 11.3x | 12.4x | 18.3x | 16.9x | 15.8x | 16.5x |
| R&D budget | 1.2b | 1.1b | 1.4b | 1.6b | - | - | - |
| R&D % of revenue | 1 % | 1 % | 1 % | 1 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Zydus Lifesciences
Edit
ACQUISITION by Zydus Lifesciences Aug 2024
ACQUISITION by Zydus Lifesciences Oct 2023